[
  {
    "info": {
      "NCT": "NCT04985604",
      "Protocol_No": "DAY 101-102",
      "jit": "Caris",
      "trial_name": "Day One Biopharmaceuticals, Inc. DAY 101-102"
    },
    "disease": {
      "summary": "Melanoma or Solid Tumors",
      "details": [
        {
          "code": "Melanoma (MEL)",
          "selection": "include"
        },
        {
          "code": "Solid Tumors",
          "selection": "include"
        }
      ]
    },
    "query": {
      "nct": "NCT04985604",
      "title": "DAY101 Monotherapy or in Combination With Other Therapies for Patients With Solid Tumors",
      "current_status": "Recruiting",
      "status_verif_date": "July 2022",
      "last_update_date": "July 27, 2022",
      "trial_hold_status": "open",
      "sponsor": "Day One Biopharmaceuticals, Inc.",
      "brief_summary": "This is a Phase 1b/2, multi-center, open label umbrella study of patients â‰¥12 years of age with recurrent or progressive solid tumors with alterations in the key proteins of the RAS/RAF/MEK/ERK pathway, referred to as the MAPK pathway..",
      "conditions": "Melanoma | Solid Tumor",
      "type": "Interventional",
      "phase": "Phase 1 | Phase 2",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "Arm #1",
          "drug": "DAY101 | NA",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Arm #1",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Fusion",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
	      "summary": "BRAF Fusion"
            },
            {
              "cohort": "Arm #1",
              "Gene": "RAF1",
              "Gene2": "Not available",
              "Type": "Fusion",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
	       "summary": "RAF1 Fusion"
            },
            {
              "cohort": "Arm #1",
              "Gene": "RAF1",
              "Gene2": "Not available",
              "Type": "Amplification",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "RAF1 Amplification  "
            }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "Arm #2",
          "drug": "DAY101 | Pimasertib Hydrochloride",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Arm #2",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Fusion",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
	       "summary": "BRAF Fusion"
            },
            {
              "cohort": "Arm #2",
              "Gene": "RAF1",
              "Gene2": "Not available",
              "Type": "Fusion",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
	       "summary": "RAF1 Fusion"
            },
            {
              "cohort": "Arm #2",
              "Gene": "RAF1",
              "Gene2": "Not available",
              "Type": "Amplification",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "RAF1 Amplification  "
            }
          ]
        }
      ],
      "docs": "Q:/MCK/MOA/Precision Oncology/JIT Trials/CarisPharmatechStudyList_2022-07-12.pdf",
      "min_age": "12 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT04985604\" target=\"_blank\">NCT04985604<\/a>"
    }
  }
]
